These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24276589)

  • 1. Effect of neoadjuvant treatment in the management of osteosarcomas of the head and neck.
    Mücke T; Mitchell DA; Tannapfel A; Wolff KD; Loeffelbein DJ; Kanatas A
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):127-31. PubMed ID: 24276589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.
    Jeon DG; Song WS; Cho WH; Kong CB; Cho SH
    Clin Orthop Relat Res; 2014 Jun; 472(6):1911-20. PubMed ID: 24574120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant radiation therapy in resected high-grade localized skeletal osteosarcomas treated with neoadjuvant chemotherapy: Long-term outcomes.
    Sole CV; Calvo FA; Alvarez E; Cambeiro M; Cuervo M; San Julian M; Sole S; Martinez-Monge R; Sierrasesumaga L
    Radiother Oncol; 2016 Apr; 119(1):30-4. PubMed ID: 26970678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcomas of the head and neck: a 10-year retrospective of 25 patients to evaluate treatment modalities, function and survival.
    Ketabchi A; Kalavrezos N; Newman L
    Br J Oral Maxillofac Surg; 2011 Mar; 49(2):116-20. PubMed ID: 20416997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post operative infection and increased survival in osteosarcoma patients: are they associated?
    Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A
    Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
    Hong S; Shin SJ; Jung M; Jeong J; Lee YJ; Shin KH; Roh JK; Rha SY
    Oncology; 2011; 80(1-2):107-17. PubMed ID: 21677455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
    Thiele OC; Freier K; Bacon C; Egerer G; Hofele CM
    Br J Oral Maxillofac Surg; 2008 Oct; 46(7):533-6. PubMed ID: 18436357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
    Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
    Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma.
    Kim MS; Lee SY; Lee TR; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    Ann Oncol; 2009 May; 20(5):955-60. PubMed ID: 19153123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.
    Cho Y; Jung GH; Chung SH; Kim JY; Choi Y; Kim JD
    Clin Orthop Surg; 2011 Mar; 3(1):48-54. PubMed ID: 21369478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.
    Iwamoto Y; Tanaka K; Isu K; Kawai A; Tatezaki S; Ishii T; Kushida K; Beppu Y; Usui M; Tateishi A; Furuse K; Minamizaki T; Kawaguchi N; Yamawaki S
    J Orthop Sci; 2009 Jul; 14(4):397-404. PubMed ID: 19662473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.
    Kosemehmetoglu K; Ardic F; Karslioglu Y; Kandemir O; Ozcan A
    Hum Pathol; 2016 Apr; 50():170-5. PubMed ID: 26997452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
    Yu W; Tang L; Lin F; Yao Y; Shen Z
    Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcomes in patients with osteogenic sarcoma of the head and neck.
    Patel SG; Meyers P; Huvos AG; Wolden S; Singh B; Shaha AR; Boyle JO; Pfister D; Shah JP; Kraus DH
    Cancer; 2002 Oct; 95(7):1495-503. PubMed ID: 12237918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults.
    Boon E; van der Graaf WT; Gelderblom H; Tesselaar ME; van Es RJ; Oosting SF; de Bree R; van Meerten E; Hoeben A; Smeele LE; Willems SM; Witjes MJ; Buter J; Baatenburg de Jong RJ; Flucke UE; Peer PG; Bovée JV; Van Herpen CM
    Head Neck; 2017 Jan; 39(1):140-146. PubMed ID: 27507299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
    Bacci G; Ferrari S; Ruggieri P; Biagini R; Fabbri N; Campanacci L; Bacchini P; Longhi A; Forni C; Bertoni F
    Acta Orthop Scand; 2001 Apr; 72(2):167-72. PubMed ID: 11372948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and neck osteosarcoma at the University of Washington.
    Oda D; Bavisotto LM; Schmidt RA; McNutt M; Bruckner JD; Conrad EU; Weymuller EA
    Head Neck; 1997 Sep; 19(6):513-23. PubMed ID: 9278760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.